The Exceptional Women Alliance Announces Selection of Dr. Roslyn F. Schneider

Dr. Schneider's career spans medicine, corporate leadership, and patient advocacy, with a consistent focus on aligning healthcare solutions with the real needs of patients. As the Principal of RozMD Patient Affairs Consulting LLC, she advises on integrating human-centered design into healthcare and biopharmaceutical research, ensuring that patient perspectives shape industry innovation.

With a background in Internal Medicine, Pulmonary, and Critical Care Medicine, Dr. Schneider has held leadership roles in hospital administration, postgraduate medical education, and global patient affairs at leading pharmaceutical companies. She established the Global Patient Affairs Office at Pfizer and has served as Vice President at Theravance and BioMarin Pharmaceutical Inc., spearheading initiatives that made patient inclusiveness a standard practice across the industry.

Beyond her corporate achievements, Dr. Schneider is a passionate mentor, advocate for gender equity in healthcare, and leader in not-for-profit organizations. She currently serves as Chair of the Board of the American Lung Association's New Jersey Chapter and Vice Chair of the GMDP Academy of King's College London. Her dedication to advancing women in leadership is reflected in her involvement with Women Execs on Boards and other professional associations.

"Roz's influence in patient-centered healthcare, biopharmaceutical research, and advocacy is truly remarkable," said Larraine Segil, Chair & CEO of EWA. "Her leadership and commitment to innovation align perfectly with EWA's mission. We are honored to welcome her to our community of extraordinary women leaders."

Dr. Schneider's contributions to medicine and patient advocacy have earned her numerous accolades, including the PharmaVoice100 Award as one of the most inspiring people in life sciences, the Strong Women in Medicine Award from the CUNY School of Medicine, and the Dean's Distinguished Alumna Service Award. A Global Fellow in Medicines Development (GMDP Academy), she also completed the Women on Boards program at Harvard and continues to shape the future of healthcare governance and leadership.

When asked about her selection, Roslyn shared her excitement, saying, "I am honored and truly delighted to be included in the Exceptional Women Alliance! I'm already uplifted by the unique warmth and connections in this remarkable sisterhood of accomplished women who support, inspire, and empower one another."

About the Exceptional Women Alliance (EWA)

The Exceptional Women Alliance (EWA) is an invitation-only peer mentorship organization where high-potential, high-level Exceptional Women from across multiple industries are hand-selected and invested in, to grow, learn, share, and succeed. In addition to the achievement of significant success, the criteria for acceptance include character traits that are defining of the EWA Culture – Kindness, the Spirit of Generosity, Transparency, Gratitude, and Willingness to Share their knowledge. The Foundation is a powerhouse of peer-to-peer mentoring that provides guidance, deep connection, and leadership, propelling each woman to sustainable personal and professional happiness, changing lives, one woman at a time. The life-long program enables each member to be connected as alumnae in the ever-expanding EWA global community, as their fellow women leaders continue to move into positions of significance. Learn more at https://www.exceptionalwomenalliance.com/ Follow us on Facebook

SOURCE Exceptional Women Alliance